Journal of Chinese Integrative Medicine ›› 2007, Vol. 5 ›› Issue (6): 634-641.doi: 10.3736/jcim20070607
Special Issue: Traditional Chinese Medicine
• Original Experimental Research • Previous Articles Next Articles
Xiu-wei Yang, Xiao-da Yang, Ying Wang, Lian Ma, Yue Zhang, Xiao-gai Yang, Kui Wang
CLC Number:
[1] | 杨秀伟 . 基于体内过程的中药有效成分和有效效应物质的发现策略[J]. 中国中药杂志, 2007,32(5):365-370 |
Yang XW . Discovery strategy for effective and active constituents of Chinese material medica based on the processes of metabolism and disposition in intra-body[J]. Zhongguo Zhong Yi Yao Za Zhi, 2007,32(5):365-370 | |
[2] | 杨秀伟 . 基于体内过程的中药毒性成分和毒性效应物质的发现策略[J]. 中华中医药杂志, 2007,22(2):67-72 |
Yang XW . Discovery strategy for toxic-invited constituents and toxic-effective substances on Chinese material medica based on the processes of metabolism and disposition in intra-body[J]. Zhong Hua Zhong Yi Yao Za Zhi, 2007,22(2):67-72 | |
[3] | 杨秀伟 . 中药实验医学研究中的关键基础科学问题[J]. 中西医结合学报, 2005,3(2):154-159 |
Yang XW . Key foundational science problem in experimental medicine study of Chinese materia medica: ascertainment of active and toxic constituents in Chinese materia medica[J]. Zhong Xi Yi Jie He Za Zhi, 2005,3(2):154-159 | |
[4] | 杨秀伟 . 中药成分的肠内和肝内行为与中药有效成分的确定[J]. 中草药, 2004,35(增刊):1-5 |
Yang XW . Relationship between confirmation of Chinese materia medica bioactive constituents and intra-intestinal and intra-hepatic behavior of Chinese materia medica active constituents[J]. Zhong Cao Yao, 2004,35(Suppl):1-5 | |
[5] | 杨秀伟, 郝美荣, 服部征雄 . 中药成分代谢分析[M]. 北京: 中国医药科技出版社,2003. |
Yang XW, Hao MR Hattori M, , . Metabolite analysis for chemical constituents of traditional Chinese medicines[M]. Beijing: China Medical-Pharmaceutical Science & Technology Publishion House, 2003. | |
[6] | 周昕 . 药物吸收体外研究方法的概述[J]. 中国临床药理学与治疗学, 2006,11(4):379-384 |
Zhou X . Study on in vitro models of drug absorption[J]. Zhongguo Lin Chuang Yao Li Xue Yu Zhi Liao Xue, 2006,11(4):379-384 | |
[7] |
Turowski GA, Rashid Z, Hong F , et al. Glutamine modulates phenotype and stimulates proliferation in human colon cancer cell lines[J]. Cancer Res, 1994,54(22):5974-5980
doi: 10.1002/1097-0142(19941115)74:10<2885::AID-CNCR2820741023>3.0.CO;2-P pmid: 7954430 |
[8] | Rashid Z, Basson MD . Topoisomerase II inhibition differentially modulates Caco-2 intestinal epithelial cell phenotype[J]. Biochem Biophy Res Comm, 1996,219(1):82-88 |
[9] | Yee SY . In vitro permeability across Caco-2 cells(colonic) can predict in vivo(small intestinal) absorption in man-fact or myth[J]. Pharm Res, 1997,14(6):763-766 |
[10] | Chong S, Dando SA, Morrison RA . Evaluation of biocoat intestinal epithelium differentiation environment(3-day cultured Caco-2 cells) as an absorption screening model with improved productivity[J]. Pharm Res, 1997,14(12):1835-1837 |
[11] | Gao JN, Hugger ED, Beck-Westermeyer MS , et al.Estimating intestinal mucosal permeation of compounds using Caco-2 cell monolayer. In ‘Current Protocols in Pharmacology.[M].Chichester:John Wiley & Sons, 2000. |
[12] |
Walle UK, French KL, Walgren RA , et al. Transport of genistein-7-glucoside by human intestinal Caco-2 cells: Potential role for MRP2[J]. Res Commun Mol Pathol Pharmacol, 1999,103(1):45-46
doi: 10.1159/000028443 pmid: 10440570 |
[13] | Tian XJ, Yang XD, Wang K , et al. The efflux of flavonoids morin, isorhamnetin-3-O-rutinoside and diosmetin-7-O-beta-D-xylopyranosyl-(1-6) -beta-D-glucopyranoside in the human intestinal cell line caco-2[J]. Pharm Res, 2006,23(8):1721-1728 |
[14] | Yang XW, Guo QM, Wang Y , et al. Intestinal permeability of antivirus constituents from the fruits of Eucalyptus globulus Labill. in Caco-2 cell model[J]. Bioorg Med Chem Lett, 2007,17(4):1107-1111 |
[15] | 田莉, 杨秀伟, 王莹 , 等. 顺式-和反式-阿霍烯在Caco-2细胞模型中的体外摄取、转运和外排特性[J]. 药学学报, 2007,42(1):87-92 |
Tian L, Yang XW, Wang Y , et al. Characteristics of uptake, transport and efflux of Z- and E-ajoenes in Caco-2 cell monolayers in vitro[J]. Yao Xue Xue Bao, 2007,42(1):87-92 | |
[16] | Yang XG, Yuan Lan, Wang K , et al. Comparison of intestinal absorption of two insulinmimic vanadyl complexes using Caco-2 monolayers as model system[J]. Chin Sci Bull, 2003,48(9):876-881 |
[17] | Zhang Y, Yang XD, Wang K , et al. The permeability and cytotoxicity of insulin-mimetic vanadium(III, IV, V)-dipicolinate complexes[J]. J Inorg Biochem, 2006,100(1):80-87 |
[18] |
Bohets H, Annaert P, Mannens G , et al. Strategies for absorption screening in drug discovery and development[J]. Curr Top Med Chem, 2001,1(5):367-383
doi: 10.2174/1568026013394886 pmid: 11899103 |
[19] | 张正全, 陆彬 . 口服结肠定位给药系统新进展[J]. 中国药学杂志, 2000,35(1):221-223 |
Mu YP, Wu G, Qiao XW , et al. The transport and absorption of chiral metal domplexes d,l-[Ni(phen)3]2+ across the model of Caco-2 cell monolayers[J]. Baotou Yi Xue Yuan Xue Bao, 2000,35(1):221-223 | |
[20] | Komura H, Shigemoto Y, Kawahara I , et al. High throughput screening of pharmacokinetics and metabolism in drug discovery(III)--investigation on in- silico model for membrane permeability and CYP1A2 inhibition[J]. Yakugaku Zasshi, 2005,125(1):141-147 |
[21] | 牟永平, 吴刚, 乔秀文 , 等. 手性金属配合物d,l-[Ni(phen)3]2+ 经Caco-2细胞单层模型的吸收转运[J]. 包头医学院学报, 2006,22(4):358-360 |
Mu YP, Wu G, Qiao XW , et al. The transport and absorption of chiral metal domplexes d,l-[Ni(phen)3]2+ across the model of Caco-2 cell monolayers[J]. Baotou Yi Xue Yuan Xue Bao, 2006,22(4):358-360 | |
[22] | Schmiedlin-Ren P, Thummel KE, Fisher JM , et al. Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3[J]. Mol Pharmacol, 1997,51(5):741-754 |
[23] | Annaert P, Kinget R, Naesens L , et al. Transport, uptake, and metabolism of the bis(pivaloyloxymethyl)-ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine in an in vitro cell culture system of the intestinal mucosa(Caco-2)[J]. Pharm Res, 1997,14(4):492-496 |
[24] | van Gelder J, Annaert P, Naesens L , et al. Inhibition of intestinal metabolism of the antiviral ester prodrug bis(POC)-PMPA by nature-identical fruit extracts as a strategy to enhance its oral absorption: an in vitro study[J]. Pharm Res, 1999,16(7):1035-1040 |
[25] | Bartels H, Korsiak E,Daniel H . Transport activity of the MDR1-gene product in monolayers of Caco-2 cells[J].Zeitschrift fur Gastroenterologie, 1994, 32 15-18 |
[26] | Dibas A, Wood J, Mia AJ et al.The ATP-depleting reagent iodoacetamide induces the degradation of protein kinase C alpha(PKCalpha) in LLC-PK1 pig kidney cells[J]. Life Sci, 1997,61(17):1697-1704 |
[27] | Tsuruo T, Iida H, Tsukagoshi S , et al. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil[J]. Cancer Res, 1981,41(5):1967-1972 |
[28] | Roepe PD . The P-glycoprotein efflux pump: how does it transport drugs?[J]. J Membr Bio, 1997,160(3):161-175 |
[29] | Leier I, Jedlitschky G, Buchholz U , et al. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates[J]. J Biol Chem, 1994,269(45):27807-27810 |
[30] | Jedlitschky G, Leier I, Buchholz U . ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein[J]. Cancer Res, 1994,54(18):4833-4836 |
[31] | Barrand MA, Bargrij T, Neo SY . Multidrug resistance-associated protein: A protein distinct from P-glycoprotein involved in cytotoxic drug expulsion[J]. Gen Pharmacol, 1997,28(5):639-645 |
[32] | Chen J, Lin H, Hu M . Absorption and metabolism of genistein and its five isoflavone analogs in the human intestinal Caco-2 model[J]. Cancer Chemother Pharmacol, 2005,55(2):159-169 |
[33] | Nikolic D, Li Y, Chadwick LR , et al. In vitro studies of intestinal permeability and hepatic and intestinal metabolism of 8-prenylnaringenin, a potent phytoestrogen from hops(Humulus lupulus L.)[J]. Pharm Res, 2006,23(5):864-872 |
[1] | Ming-hui Yang, Min Li, Yong-qi Dou, Yi Liu, Xiao-dong Luo, Jian-zong Chen, Heng-jun Shi. Effects of Bushen Huoxue Granule on motor function in patients with Parkinson’s disease: A multicenter, randomized, double-blind and placebo-controlled trial. Journal of Chinese Integrative Medicine, 2010, 8(3): 231-237. |
[2] | Ya-bing Zhou, Jian-er Yu, Jie Wu, Li Bai, Li-li Huo, Xin-guang Zhang, Li-qing Li . Effects of Chinese herbal medicine Bushen Gubiao Recipe on toll-like receptor 4 and CD4 +CD25 +foxp3 +regulatory T cells in mice with recurrent respiratory tract infections. Journal of Chinese Integrative Medicine, 2010, 8(11): 1053-1059. |
[3] | Bing Hu , Hong-mei An , Ke-ping Shen , Qin Du. Senescence-inducing effects of Chinese herbal medicine Tenglong Buzhong Decoction on human colon carcinoma LS-174-T cells and the mechanism. Journal of Chinese Integrative Medicine, 2010, 8(11): 1048-1052. |
[4] | Wei Xu, Meng Shi, Jian-gang Liu, Cheng-long Wang . Collagen protein expressions in ischemic myocardium of rats with acute myocardial infarction and effects of qi-tonifying, yin-tonifying and blood-activating herbs and detoxifying and blood-activating herbs. Journal of Chinese Integrative Medicine, 2010, 8(11): 1041-1047. |
[5] | Wen-jun Wang, Da-jin Li, Jun Li, Wen-jiang Zhou. An in vitro study on neuroprotective effects of serum containing Gengnianchun decoction and its main monomers against amyloid beta protein-induced cellular toxicity. Journal of Chinese Integrative Medicine, 2010, 8(1): 67-73. |
[6] | Li Yan, Xian-chuan Chen, Jian Guo, Li-li Qi, Yi-ming Qian, Xiong-gen Zhou. Prevention of hospital-acquired pneumonia with Yupingfeng Powder in patients with acute cerebral vascular diseases: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2010, 8(1): 25-29. |
[7] | Xin-yue Zhi . Traditional Chinese medicine diagnosis and treatment of type 2 diabetes in Tianjin urban population. Journal of Chinese Integrative Medicine, 2009, 7(9): 823-826. |
[8] | Deng-hao Liu, Zheng Wang, Zhang-yan Qin. Clinical effects of Shugan Jianpi Recipe on postadolescent acne in women. Journal of Chinese Integrative Medicine, 2009, 7(7): 671-673. |
[9] | Xin-jun Liu, Shi-bing Su. Study of combination methods for formula composition of Chinese herbal medicines and their components. Journal of Chinese Integrative Medicine, 2009, 7(7): 601-606. |
[10] | Xian-jun Tong, Xiao-yu Xiang, Zun-hua Cheng, Li Chen, Xian-chuan Chen, Jing-xian Chen. Color Doppler ultrasound evaluation of a Chinese herbal formula in treating lower limb arteriosclerosis: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2009, 7(6): 518-521. |
[11] | Ai-ping Lu, Xue-wen Liu, Xiao-rong Ding. Methodology of pharmacodynamic evaluation on Chinese herbal medicine based on syndrome differentiation. Journal of Chinese Integrative Medicine, 2009, 7(6): 501-504. |
[12] | Jia Guo , Rui-ming Zhang, Zong-wen Huang, Lei Wang, Song-shan Liu, Jun-cheng Diao, Si-yuan Hu, Bing-hui Lin. Yunchang Capsule in treatment of functional constipation: A randomized, double-blinded controlled, multicenter trial. Journal of Chinese Integrative Medicine, 2009, 7(12): 1123-1129. |
[13] | Wen Cao, Ai-guang Zhao . Prescription rules of Chinese herbal medicines in treatment of gastric cancer. Journal of Chinese Integrative Medicine, 2009, 7(1): 1-8. |
[14] | Chung-wah Cheng, Zhao-xiang Bian, You-ping Li, David Moher, Tai-xiang Wu, Simon Dagenais, Jing Li, Ting-qian Li. Transparently reporting adverse effects of traditional Chinese medicine interventions in randomized controlled trials. Journal of Chinese Integrative Medicine, 2008, 6(9): 881-886. |
[15] | Jian-li Ni, Pan Zhang, Fu-yao Ren. Laws of compound traditional Chinese medicine in treatment of dysmenorrhea. Journal of Chinese Integrative Medicine, 2008, 6(8): 783-787. |
|